Invitation to presentation of BioArctic's second quarter report for April - June 2025 on August 28 at 9.30 a.m. CET
BioArctic AB (NASDAQ Stockholm: BIOA B) has announced the upcoming release of its Q2 2025 financial report on August 28, 2025, at 08:00 a.m. CET. The company will host an audiocast with teleconference in English at 09:30 CET featuring CEO Gunilla Osswald, CFO Anders Martin-Löf, and other executives who will present and discuss the quarterly results.
The presentation will be accessible via webcast and teleconference, with opportunities for participants to ask questions either written or verbally. The webcast recording will be available on-demand through BioArctic's corporate website after the event.
BioArctic AB (NASDAQ Stockholm: BIOA B) ha annunciato la pubblicazione del rapporto finanziario relativo al secondo trimestre 2025, prevista per il 28 agosto 2025 alle 08:00 CET. L'azienda terrà un audiocast con teleconferenza in inglese alle 09:30 CET, durante il quale la CEO Gunilla Osswald, il CFO Anders Martin-Löf e altri dirigenti presenteranno e commenteranno i risultati trimestrali.
La presentazione sarà fruibile via webcast e teleconferenza, con la possibilità per i partecipanti di porre domande in forma scritta o orale. La registrazione del webcast sarà disponibile on‑demand sul sito corporate di BioArctic dopo l'evento.
BioArctic AB (NASDAQ Stockholm: BIOA B) ha anunciado la publicación de su informe financiero del segundo trimestre de 2025, prevista para el 28 de agosto de 2025 a las 08:00 CET. La compañía ofrecerá un audiocast con teleconferencia en inglés a las 09:30 CET, en el que la CEO Gunilla Osswald, el CFO Anders Martin-Löf y otros directivos presentarán y comentarán los resultados trimestrales.
La presentación será accesible por webcast y teleconferencia, con oportunidades para que los participantes formulen preguntas por escrito o de forma oral. La grabación del webcast estará disponible on‑demand en la web corporativa de BioArctic tras el evento.
BioArctic AB (NASDAQ Stockholm: BIOA B)는 2025년 2분기 재무보고서를 2025년 8월 28일 오전 08:00 CET에 발표할 예정이라고 밝혔습니다. 회사는 09:30 CET에 영어로 진행되는 오디오캐스트 및 전화회의를 개최하며, CEO Gunilla Osswald, CFO Anders Martin-Löf 및 기타 경영진이 분기 실적을 발표하고 논의합니다.
발표는 웹캐스트 및 전화회의를 통해 시청할 수 있으며, 참가자는 서면 또는 구두로 질문할 기회를 가집니다. 웹캐스트 녹화는 행사 후 BioArctic 기업 웹사이트에서 온디맨드로 제공됩니다.
BioArctic AB (NASDAQ Stockholm: BIOA B) a annoncé la publication de son rapport financier du deuxième trimestre 2025, prévue le 28 août 2025 à 08:00 CET. La société organisera un audiocast avec téléconférence en anglais à 09:30 CET, durant lequel la PDG Gunilla Osswald, le directeur financier Anders Martin-Löf et d'autres dirigeants présenteront et commenteront les résultats trimestriels.
La présentation sera accessible via webcast et téléconférence, avec la possibilité pour les participants de poser des questions par écrit ou oralement. L'enregistrement du webcast sera disponible à la demande sur le site corporate de BioArctic après l'événement.
BioArctic AB (NASDAQ Stockholm: BIOA B) hat die Veröffentlichung seines Finanzberichts für das zweite Quartal 2025 angekündigt, die für den 28. August 2025 um 08:00 Uhr CET geplant ist. Das Unternehmen wird um 09:30 CET einen Audiocast mit Telefonkonferenz in englischer Sprache veranstalten, bei dem CEO Gunilla Osswald, CFO Anders Martin-Löf und weitere Führungskräfte die Quartalsergebnisse vorstellen und erörtern.
Die Präsentation ist per Webcast und Telefonkonferenz zugänglich; Teilnehmer können Fragen schriftlich oder mündlich stellen. Die Aufzeichnung des Webcasts wird nach der Veranstaltung on‑demand auf der Unternehmenswebsite von BioArctic verfügbar sein.
- None.
- None.
In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on August 28, at 09:30 CET, where Gunilla Osswald, CEO, Anders Martin-Löf, CFO, and colleagues will present and comment on the second quarter report, followed by a Q&A-session.
If you wish to participate via webcast, please use the link below. Via the webcast you will be able to ask written questions.
Webcast: https://bioarctic.events.inderes.com/q2-report-2025/register
If you wish to participate via teleconference, please register on the link below. After registration you will be provided with phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
https://events.inderes.com/bioarctic/q2-report-2025/dial-in
The webcast will also be available on demand on BioArctic's corporate website https://www.bioarctic.com/en/investors/financial-reports-and-presentations/ after the presentation.
For more information, please contact:
Oskar Bosson, VP Communications and Investor Relations
E-mail: oskar.bosson@bioarctic.com
Tel: + 46 704 10 71 80
This information was submitted for publication at 09:00 a.m. CET on August 21, 2025.
About BioArctic AB
BioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company invented Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been developed together with BioArctic's partner Eisai, who are responsible for regulatory interactions and commercialization globally. In addition to Leqembi, BioArctic has a broad research portfolio with antibodies against Parkinson's disease and ALS as well as additional projects against Alzheimer's disease. Several of the projects utilize the company's proprietary BrainTransporter™ technology, which has the potential to actively transport antibodies across the blood-brain barrier to enhance the efficacy of the treatment. BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For further information, please visit www.bioarctic.com.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Invitation to presentation of BioArctic’s second quarter report for April â€" June 2025 on August 28 |
View original content:https://www.prnewswire.com/news-releases/invitation-to-presentation-of-bioarctics-second-quarter-report-for-april--june-2025-on-august-28-at-9-30-am-cet-302535589.html
SOURCE BioArctic
FAQ
When will BioArctic (BIOA) release its Q2 2025 earnings report?
How can investors participate in BioArctic's Q2 2025 earnings call?
Who will present during BioArctic's Q2 2025 earnings call?
Where can I find the replay of BioArctic's Q2 2025 earnings presentation?
